ECTRIMS 2022

26.10.2022 - 28.10.2022, Amsterdam, Niederlande

Fachbereich: Neurologie

It has been 11 years since the previous ECTRIMS Congress in Amsterdam. The world has changed since then. The recent pandemic has had a huge impact on the world as a whole and also on the scientific community. The coronavirus prompted accelerated worldwide collaborations focusing on the consequences of the viral infection. The impact of COVID-19 and the vaccination on people with MS – on and off disease-modifying treatment – was studied jointly. Borders between countries seemed to fade. At the same time, it became more complicated to cross borders physically and much progress has been made using online solutions. Meeting colleagues became ‘virtual’, although real. But in the past 11 years also our knowledge on many aspects of MS has increased and progress has been made in treatment options and care for those suffering from the disease. The diagnosis of MS and related diseases can be made at an earlier stage, leading to a timely start of an individualised treatment strategy aimed at minimising the impact of the disease and maintaining an optimal quality of life.

However, there is no reason for leaning back as long as MS cannot be cured completely. Every facet of the disease needs careful attention and translational research is needed to bridge “bench and bedside”. Therefore it is great that the all-year-round collaborative efforts and networking amongst those involved in MS research from all over the world brings us together again at the yearly congress. To exchange our results, to share our newest insights and to strengthen our network. Together with the local organizing committee, a programme has been composed that should facilitate all these elements.

Also in Amsterdam Scientific Sessions, Hot Topic Sessions and Educational Sessions will be held, but also selected Free Communications, Young Investigator Sessions, guided e-Poster Sessions and Meet-the-Expert Sessions. And in between many opportunities to tighten ties with friends and colleagues and make new contacts with all who share the same ideal: to solve the puzzle of MS. Next years’ Congress will be truly hybrid, so everyone can join digitally. But we hope that 2022 allows for crossing borders again. Physically by coming to the wonderful city of Amsterdam and enjoy not only the Congress but also everything that the city has to offer. And scientifically by connecting with colleagues from other disciplines and continue to build a network strong enough to halt the disease and make a difference in the future.